Florida Hospital Cancer Institute: New Executive Medical Director Brings Thoracic Oncology Expertise
Year after year, lung cancer continues to earn its reputation as the silent epidemic. It is the number one cancer killer of women. Yet with nearly twice as many female lives lost than any other cancer, only 1% think of it as a disease that can impact them. The fact is, this year alone, more than 71,000 women are estimated to lose their lives.
The Florida Hospital Cancer Institute is working hard to address this critical women’s health issue. Recently, the Institute named Dr. Mark Socinski, a leading expert in thoracic malignancies, the Executive Medical Director. “I don’t think enough people realize that one woman dies every eight minutes in the United States of lung cancer,” said Dr. Socinski. “This year, the Institute will introduce a state-of-the-art lung cancer clinic. The focus will be twofold: state-of-the-art care for lung cancer patients by leading experts in the disease and clinical trials that offer new and novel therapies to treat this cancer.”
Doing More For Women with Lung Cancer
When it comes to at-risk women, the new Florida Hospital Lung Cancer Clinic will offer the expertise and technology needed to make a critical difference. Their full-spectrum of services will include medical oncology, radiation oncology, pulmonary medicine and thoracic surgery ensuring a multi-disciplinary approach for all patients.
Are You Considered At-Risk for Lung Cancer?
Currently, lung cancer screening is recommended and covered by most insurance plans and Medicare if you meet the following criteria: a current recent smoker (quit within the past 15-years), between the ages of 55-80 and have a smoking history of 30 years or more (calculated as an average of one pack a day for 30 years, two packs a day for 15 years, etc.). If this sounds like you or a loved one, regular screenings are essential.
Meet Mark Socinski, MD, Executive Medical Director, Florida Hospital Cancer Institute
Dr. Socinski specializes in thoracic malignancies, including small cell and non-small cell lung cancers and mesothelioma. He is board certified in internal medicine and medical oncology, has extensive experience in research and clinical trials, and has spent more than 20 years in academia. At University of Pittsburgh Medical Center (UPMC) Cancer Pavilion, he served as Professor of Medicine and Cardiovascular Surgery; Director of the Lung Cancer Section for the Division of Hematology and Oncology; Co-director of the Lung Cancer Center of Excellence; and Co-director of the Lung Cancer Program. Before joining UPMC, Dr. Socinski was Professor of Medicine at the University of North Carolina Department of Medicine. He is a member of the American Society of Clinical Oncology, the American College of Physicians, the International Association for the Study of Lung Cancer, and the American College of Chest Physicians. Dr. Socinski received his medical degree as well as a Master’s of Science in Pathology from the University of Vermont College of Medicine. He completed his residency at Beth Israel Deaconess Medical Center in Boston and completed fellowships at Dana-Farber Cancer Institute in Boston and Harvard Medical School.
For more information about the lung cancer program at the Florida Hospital Cancer Institute, visit FloridaHospitalLung.com.